Neuroinflammation, oxidative stress and their interplay in neuropathic pain: Focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies
- 5 November 2020
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 162, 105280
- https://doi.org/10.1016/j.phrs.2020.105280
Abstract
No abstract availableFunding Information
- Universidade do Porto/FMUP
- European Social Fund
This publication has 285 references indexed in Scilit:
- NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administrationGlia, 2013
- Resolvin E1 Inhibits Neuropathic Pain and Spinal Cord Microglial Activation Following Peripheral Nerve InjuryJournal of Neuroimmune Pharmacology, 2012
- Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseNeurobiology of Aging, 2012
- Resolvin E1 maintains macrophage function under cigarette smoke‐induced oxidative stressFEBS Open Bio, 2012
- Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathyExperimental Neurology, 2011
- Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2Free Radical Biology & Medicine, 2011
- The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuriesNeuroscience, 2011
- MAP kinase and painBrain Research Reviews, 2009
- Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patientsJournal of Neuroimmunology, 2008
- Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cellsExperimental Eye Research, 2007